Utah Medical Products Extends $75.00 Tender Offer to October 27
Utah Medical Products has extended the expiration date of its tender offer, giving stockholders additional time to consider the offer and the company’s scheduled calendar 3Q 2026 results.
Utah Medical Products, Inc. (Nasdaq: UTMD) has extended the deadline for its offer to purchase up to 650,000 shares of its common stock at $75.00 per share. The offer is now scheduled to expire at 5:00 p.m. New York City time on Tuesday October 27.
The offer was originally due to expire at 5:00 p.m. New York City time on Wednesday October 7. Utah Medical Products said the additional time is intended to give stockholders sufficient time to decide whether to participate.
The revised timetable also allows stockholders to consider the company’s latest financial results for calendar 3Q 2026, which are scheduled to be announced on Thursday October 22.
Utah Medical Products said the expiration date is the only change to the offer. All other conditions remain in place and are described in the SEC Form TO-IA Offer to Purchase and Letter of Transmittal filed with the SEC.
Stockholders, or their broker, dealer, commercial bank, trust company or other nominee, should send or deliver the Letter of Transmittal, certificates for shares and any other required documents to the Depositary at the address specified in the tender offer materials.
Utah Medical Products develops, manufactures and markets disposable and reusable specialty medical devices. The company has a particular interest in health care for women and their babies, and says clinicians in over a hundred countries recognise its products as the standard for obtaining optimal long-term outcomes for their patients.
Utah Medical Products, Inc. announced that it is extending the expiration date of its offer to purchase up to 650,000 shares of its common stock at $75.00 per share.
Utah Medical Products, Inc.'s offer is now scheduled to expire at 5:00 p.m. New York City time, on Tuesday October 27.
The offer was initially scheduled to expire at 5:00 p.m. New York City time, on Wednesday October 7.
Utah Medical Products, Inc. said the extension is intended to allow all stockholders sufficient time to make their decisions. It also gives stockholders the opportunity to consider the company's latest financial results for calendar 3Q 2026, which are scheduled to be announced on Thursday October 22.
Utah Medical Products, Inc. is offering to purchase up to 650,000 shares of its common stock at $75.00 per share.
Utah Medical Products, Inc. said that, except for the extended expiration date, all the conditions of the offer remain the same. Those conditions are explained in detail by reference in the SEC Form TO-IA Offer to Purchase and Letter of Transmittal filed with the SEC.
Shareholders, or their broker, dealer, commercial bank, trust company or other nominee, should send or deliver the Letter of Transmittal, certificates for shares and any other required documents to the Depositary at the address set out in the tender offer materials.
Utah Medical Products, Inc.'s latest financial results for calendar 3Q 2026 are scheduled to be announced on Thursday October 22.
Utah Medical Products, Inc. develops, manufactures and markets disposable and reusable specialty medical devices, with particular interest in health care for women and their babies. The company says its products are recognised by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients.
Utah Medical Products, Inc. shares trade on Nasdaq under the ticker symbol UTMD.